Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 229 clinical trials
featured
Management of Acute Stroke Patients on Treatment with New Oral Anticoagulants: Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry”

Management of Acute Stroke Patients on Treatment with New Oral Anticoagulants: Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry”

  • 284 views
  • 25 Mar, 2021
  • 1 location
featured
Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry

Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry

  • 68 views
  • 08 Nov, 2020
  • 1 location
featured
Do you suffer from Hemorrhoids?

Do you suffer from Hemorrhoids?

  • 1316 views
  • 25 Mar, 2021
  • 1 location
featured
BRIDGE: Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery

BRIDGE: Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery

  • 40 views
  • 25 Mar, 2021
  • 1 location
Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes

NOAH is an investigator-initiated, prospective, parallel-group, double-blind, randomised, multi-centre trial. The objective of the trial is to demonstrate that oral anticoagulation using the NOAC edoxaban is superior to current therapy to pre-vent stroke, systemic embolism, or cardiovascular death in patients with AHRE and at least two stroke risk factors but …

  • 0 views
  • 23 Jan, 2021
  • 16 locations
The Efficacy and Safety of Non-vItamiN K antaGonist oraL Anticoagulants for intermEdiate Stroke Risk in Patients With Atrial Fibrillation (SINGLE-AF)

The purpose of this study is to investigate the efficacy and safety of non-vitamin K antagonist oral anticoagulants (NOAC) in atrial fibrillation patients with intermediate stroke risk (CHA2DS2

  • 0 views
  • 25 Jan, 2021
AnticoaguLation ONE Year After Ablation of Atrial Fibrillation in Patients With Atrial Fibrillation (ALONE AF Study)

, anticoagulation can increase the risk of bleeding, the study evaluating the role of oral anticoagulation is needed in this patients. This study will compare the efficacy and safety of non-vitamin K anticoagulants

  • 0 views
  • 24 Jan, 2021
STOPping Anticoagulation for Isolated or Incidental Subsegmental Pulmonary Embolism

(SSPE). Anticoagulants are used to treat SSPE and work by preventing new clots from forming whilst the body's own mechanisms break down the clots, however they can also increase the risk of major and

  • 0 views
  • 25 Apr, 2021
  • 1 location
Clinical Study of Argatroban in the Treatment of Acute Progressive Ischemic Stroke

thrombin inhibitor. Its mechanism of action is to bind and inactivate thrombin (factor a) directly.Compared with traditional anticoagulants, argatroban not only has the advantages of good anticoagulant

  • 0 views
  • 25 Jan, 2021
  • 6 locations
Assessment of TRanscathetEr and Surgical Aortic BiOprosthetic Valve Thrombosis and Its TrEatment With Anticoagulation

This is a prospective study designed to evaluate the structural and functional integrity of transcatheter or surgical bioprosthetic valves with multimodality imaging. The study further aims to confirm resolution of the early bioprosthetic valve thrombotic changes with anticoagulation.

  • 0 views
  • 26 Jan, 2021
  • 1 location